COVID Isolation Eating Scale (CIES): Analysis of the impact of confinement in eating disorders and obesity-A collaborative international study.


Journal

European eating disorders review : the journal of the Eating Disorders Association
ISSN: 1099-0968
Titre abrégé: Eur Eat Disord Rev
Pays: England
ID NLM: 9436977

Informations de publication

Date de publication:
11 2020
Historique:
received: 03 08 2020
accepted: 04 08 2020
pubmed: 22 9 2020
medline: 17 12 2020
entrez: 21 9 2020
Statut: ppublish

Résumé

Confinement during the COVID-19 pandemic is expected to have a serious and complex impact on the mental health of patients with an eating disorder (ED) and of patients with obesity. The present manuscript has the following aims: (1) to analyse the psychometric properties of the COVID Isolation Eating Scale (CIES), (2) to explore changes that occurred due to confinement in eating symptomatology; and (3) to explore the general acceptation of the use of telemedicine during confinement. The sample comprised 121 participants (87 ED patients and 34 patients with obesity) recruited from six different centres. Confirmatory Factor Analyses (CFA) tested the rational-theoretical structure of the CIES. Adequate goodness-of-fit was obtained for the confirmatory factor analysis, and Cronbach alpha values ranged from good to excellent. Regarding the effects of confinement, positive and negative impacts of the confinement depends of the eating disorder subtype. Patients with anorexia nervosa (AN) and with obesity endorsed a positive response to treatment during confinement, no significant changes were found in bulimia nervosa (BN) patients, whereas Other Specified Feeding or Eating Disorder (OSFED) patients endorsed an increase in eating symptomatology and in psychopathology. Furthermore, AN patients expressed the greatest dissatisfaction and accommodation difficulty with remote therapy when compared with the previously provided face-to-face therapy. The present study provides empirical evidence on the psychometric robustness of the CIES tool and shows that a negative confinement impact was associated with ED subtype, whereas OSFED patients showed the highest impairment in eating symptomatology and in psychopathology.

Identifiants

pubmed: 32954595
doi: 10.1002/erv.2784
pmc: PMC7537123
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

871-883

Subventions

Organisme : Department of Health
ID : 14/68/09
Pays : United Kingdom
Organisme : Ministerio de Economía y Competitividad
ID : PSI2015-68701-R
Pays : International
Organisme : Fondo Investigación Sanitario- FIS
ID : INT19/00046
Pays : International
Organisme : Consejo Nacional de Ciencia y Tecnología
Pays : International
Organisme : Fondo Investigación Sanitario- FIS
ID : PI17/01167
Pays : International
Organisme : European Regional Development Fund
Pays : International
Organisme : Portuguese Foundation for Science and Technology grant
ID : POCI-01-0145-FEDER-028145
Pays : International
Organisme : Fondo Investigación Sanitario- FIS
ID : FIS
Pays : International
Organisme : Generalitat de Catalunya
Pays : International

Informations de copyright

© 2020 Eating Disorders Association and John Wiley & Sons Ltd.

Références

Adm Policy Ment Health. 2020 Jul;47(4):489-491
pubmed: 32333227
Psychol Methods. 2012 Jun;17(2):137-52
pubmed: 22545595
Addiction. 2020 Jun;115(6):1007-1010
pubmed: 32250482
J Couns Psychol. 2011 Jul;58(3):410-23
pubmed: 21574694
Eur Eat Disord Rev. 2020 Nov;28(6):864-870
pubmed: 32729139
Infect Dis Poverty. 2018 Aug 16;7(1):92
pubmed: 30134982
Eur Psychiatry. 2018 Oct;54:109-116
pubmed: 30193141
Am J Addict. 2020 Jul;29(4):268-270
pubmed: 32500608
Eur Eat Disord Rev. 2018 Jul;26(4):329-336
pubmed: 29902351
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Eur Eat Disord Rev. 2020 Nov;28(6):799-815
pubmed: 32974994
J Transcult Nurs. 2005 Oct;16(4):289-97
pubmed: 16160191
Can J Psychiatry. 2009 May;54(5):302-11
pubmed: 19497162
Eur Eat Disord Rev. 2019 Jul;27(4):410-420
pubmed: 31020776
J Behav Addict. 2020 Apr 29;9(2):184-186
pubmed: 32352927
Int J Ment Health Addict. 2020 May 11;:1-12
pubmed: 32395096
JAMA Netw Open. 2020 May 1;3(5):e2010185
pubmed: 32463467
Indian J Public Health. 2020 Jun;64(Supplement):S201-S204
pubmed: 32496255
Eur Eat Disord Rev. 2020 May;28(3):239-245
pubmed: 32346977
Int J Eat Disord. 2020 Nov;53(11):1780-1790
pubmed: 32720399
BMC Health Serv Res. 2018 Apr 5;18(1):251
pubmed: 29622025
Eur Eat Disord Rev. 2020 Nov;28(6):836-846
pubmed: 32754986
Eur Eat Disord Rev. 2020 Nov;28(6):871-883
pubmed: 32954595
Health Psychol. 2009 Jan;28(1):91-100
pubmed: 19210022
JMIR Ment Health. 2020 Aug 28;7(8):e21108
pubmed: 32658857
Am J Emerg Med. 2012 Feb;30(2):275-82
pubmed: 21208765
Eur Eat Disord Rev. 2020 Nov;28(6):826-835
pubmed: 32643844
J Anxiety Disord. 2020 May;72:102232
pubmed: 32408047
Int J Ment Health Addict. 2020 Mar 27;:1-9
pubmed: 32226353
Global Health. 2012 Jun 13;8:15
pubmed: 22695277
Riv Psichiatr. 2020 May-Jun;55(3):145-151
pubmed: 32489191
JAMA Psychiatry. 2020 Sep 1;77(9):974-976
pubmed: 32352480
Int J Eat Disord. 2020 Jul;53(7):1166-1170
pubmed: 32476175
Ir J Psychol Med. 2020 Sep;37(3):164-168
pubmed: 32434597
Eur Eat Disord Rev. 2018 Jan;26(1):53-61
pubmed: 29168283
Eat Weight Disord. 2020 Jun 1;:
pubmed: 32488728
J Behav Addict. 2020 Jun;9(2):181-183
pubmed: 32663384
Eur Eat Disord Rev. 2019 May;27(3):236-246
pubmed: 30334309
Eur Eat Disord Rev. 2020 Sep;28(5):483-491
pubmed: 32797731
Compr Psychiatry. 2020 Jul;100:152180
pubmed: 32422427
Int J Ment Health Addict. 2020 May 4;:1-10
pubmed: 32372892
Psychiatry Res. 2020 May;287:112934
pubmed: 32229390
Int J Environ Res Public Health. 2020 Jun 10;17(11):
pubmed: 32532077
Psychol Health Med. 2021 Jan;26(1):13-22
pubmed: 32223317
Eat Disord. 2020 Jul 9;:1-23
pubmed: 32644868
Eur Eat Disord Rev. 2020 Nov;28(6):855-863
pubmed: 32815293
Eur Eat Disord Rev. 2019 Mar;27(2):147-160
pubmed: 30084217
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Int J Eat Disord. 2020 Jun;53(6):907-916
pubmed: 32239725
Obesity (Silver Spring). 2020 Jun;28(6):1008-1009
pubmed: 32227671
Eur Eat Disord Rev. 2017 Sep;25(5):329-343
pubmed: 28544668
Eur Eat Disord Rev. 2017 Sep;25(5):389-396
pubmed: 28675592
J Addict Med. 2020 Jul/Aug;14(4):e10-e12
pubmed: 32433365
Lancet Psychiatry. 2020 Oct;7(10):883-892
pubmed: 32707037

Auteurs

Fernando Fernández-Aranda (F)

Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Barcelona, Spain.
Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.

Lucero Munguía (L)

Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.

Gemma Mestre-Bach (G)

Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
Universidad Internacional de La Rioja, Logroño, La Rioja, Spain.

Trevor Steward (T)

Melbourne School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.

Mikel Etxandi (M)

Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.

Isabel Baenas (I)

Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Barcelona, Spain.

Roser Granero (R)

CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Barcelona, Spain.
Department of Psychobiology and Methodology, School of Psychology, Universitat Autònoma de Barcelona, Barcelona, Spain.

Isabel Sánchez (I)

Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Barcelona, Spain.

Emilio Ortega (E)

Endocrinology and Nutrition Division, Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain.

Alba Andreu (A)

Endocrinology and Nutrition Division, Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.

Violeta L Moize (VL)

Endocrinology and Nutrition Division, Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain.

Jose M Fernández-Real (JM)

CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Barcelona, Spain.
Unit of Diabetes, Endocrinology and Nutrition, Hospital de Girona Dr. Josep Trueta and Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona, Spain.

Francisco J Tinahones (FJ)

CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Barcelona, Spain.
Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital and Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.

Carlos Diegüez (C)

CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Barcelona, Spain.
Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.

Gema Frühbeck (G)

CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Barcelona, Spain.
Metabolic Research Laboratory, Clínica Universidad de Navarra, University of Navarra-IdiSNA, Pamplona, Spain.

Daniel Le Grange (D)

Eating Disorders Program, Department of Psychiatry, University of California, San Francisco, California, USA.

Kate Tchanturia (K)

Section of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
D. Uznadze Institute of Psychology, Ilia State University, Tbilisi, Georgia.

Andreas Karwautz (A)

Eating Disorders Unit, Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria.

Michael Zeiler (M)

Eating Disorders Unit, Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria.

Angela Favaro (A)

Department of Neuroscience, University of Padua and Neuroscience Center (PNC), Padua, Italy.

Laurence Claes (L)

Faculty of Psychology and Educational Sciences, KU Leuven, Leuven, Belgium.
Faculty of Medicine and Health Sciences, University Antwerp, Antwerp, Belgium.

Koen Luyckx (K)

Faculty of Medicine and Health Sciences, University Antwerp, Antwerp, Belgium.
UNIBS, University of the Free State, Bloemfontein, South Africa.

Ia Shekriladze (I)

D. Uznadze Institute of Psychology, Ilia State University, Tbilisi, Georgia.

Eduardo Serrano-Troncoso (E)

Child and Adolescent Psychiatry and Psychology Department, Hospital Sant Joan de Déu and Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.

Teresa Rangil (T)

Department of Psychiatry, Germans Trias i Pujol University Hospital-IGTP, Barcelona, Spain.
Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.

Maria Eulalia Loran Meler (MEL)

Department of Psychiatry, Germans Trias i Pujol University Hospital-IGTP, Barcelona, Spain.

Jose Soriano-Pacheco (J)

Department of Psychiatry, Hospital de la Santa Creu i Sant Pau e Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), ISCIII, Madrid, Spain.

Mar Carceller-Sindreu (M)

Department of Psychiatry, Hospital de la Santa Creu i Sant Pau e Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), ISCIII, Madrid, Spain.

Sara Bujalance-Arguijo (S)

Associació Contra l'Anorèxia i la Bulímia (ACAB), Barcelona, Spain.

Meritxell Lozano (M)

FITA Foundation, Barcelona, Spain.

Raquel Linares (R)

FITA Foundation, Barcelona, Spain.

Carlota Gudiol (C)

Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Infectious Diseases Department, Hospital Universitari Bellvitge, Institut de Investigació Biomedica de Bellvitge (IDIBELL) and Institut Català d'Oncologia-Hospitalet, IDIBELL, Barcelona, Spain.
REIPI (Spanish Network for Research in Infectious Disease), Instituto de Salud Carlos III, Madrid, Spain.

Jordi Carratala (J)

Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Infectious Diseases Department, Hospital Universitari Bellvitge, Institut de Investigació Biomedica de Bellvitge (IDIBELL) and Institut Català d'Oncologia-Hospitalet, IDIBELL, Barcelona, Spain.
REIPI (Spanish Network for Research in Infectious Disease), Instituto de Salud Carlos III, Madrid, Spain.

Jessica Sanchez-Gonzalez (J)

Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.

Paulo Pp Machado (PP)

Psychotherapy and Psychopathology Research Unit - Psychology Research Center, School of Psychology, University of Minho, Braga, Portugal.

Anders Håkansson (A)

Department of Clinical Sciences Lund, Psychiatry, Faculty of Medicine, Lund University, Lund, Sweden.
Gambling Disorder Unit, Malmö Addiction Center, Malmö, Sweden.

Ferenc Túry (F)

Institute of Behavioural Sciences, Semmelweis University, Budapest, Hungary.

Bea Pászthy (B)

Institute of Behavioural Sciences, Semmelweis University, Budapest, Hungary.
1st Department of Paediatrics, Semmelweis University, Budapest, Hungary.

Daniel Stein (D)

Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Hana Papezová (H)

Department of Psychiatry, 1st Medical Faculty of Charles University, Prague, Czech Republic.

Brigita Bax (B)

Vilnius University Eating Disorders Center, Vilnius, Lithuania.

Mikhail F Borisenkov (MF)

Institute of Physiology Komi Science Center UB RAS, Syktyvkar, Russian Federation.

Sergey V Popov (SV)

Institute of Physiology Komi Science Center UB RAS, Syktyvkar, Russian Federation.

Youl-Ri Kim (YR)

Department of Psychiatry, Seoul Paik Hospital, Inje University, Seoul, South Korea.

Michiko Nakazato (M)

International University of Health and Welfare - Psychiatry, Narita, Japan.

Nathalie Godart (N)

CESP, Univ. Paris-Sud, UVSQ, INSERM U 1178, Université Paris-Saclay [Paris-Saclay University], Villejuif, France.
Department of Psychiatry, Institut Mutualiste Montsouris, School of Medicine, Université Paris Descartes, Paris, France.
UFR des Sciences de la Santé Simone Veil (UVSQ), Praticienne Hospitalière, Fondation Santé des Etudiants de France, Paris, France.

Robert van Voren (R)

Vytautas Magnus University, Kaunas, Lithuania.

Tetiana Ilnytska (T)

Institute of Psychiatry of Taras Shevchenko, National University of Kyiv, Kyiv, Ukraine.

Jue Chen (J)

Department of Clinical Psychology, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Katie Rowlands (K)

Section of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Janet Treasure (J)

Section of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Susana Jiménez-Murcia (S)

Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Barcelona, Spain.
Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH